Literature DB >> 16702165

JunD/AP-1 and STAT3 are the major enhancer molecules for high Bcl6 expression in germinal center B cells.

Eggi Arguni1, Masafumi Arima, Nobuhide Tsuruoka, Akemi Sakamoto, Masahiko Hatano, Takeshi Tokuhisa.   

Abstract

The Bcl6 proto-oncogene, which encodes a transcriptional repressor, is ubiquitously expressed and predominantly in germinal center (GC) B cells. Although the promoter region of the human Bcl6 gene has been reported, enhancer molecules for its high expression in GC B cells were largely unknown. Here we show that transcriptional start sites of the murine Bcl6 gene were different from the reported human one. DNA sequence around the new promoter region is highly conserved between mice and humans and has no canonical TATA or CCAAT box. Two AP-1-binding elements in the promoter region were the major enhancer elements in GC-derived B lymphoma cells, and JunD/AP-1 was detected in GC B cells. In addition, we identified the silencer region with three Bcl6-binding elements around the start site. Bcl6 bound to the silencer elements and its over-expression repressed the promoter activity through the elements. Activated STAT factors (STATs), especially activated STAT3, also bound to the silencer elements in GC B cells and competed with Bcl6 for the binding, suggesting that JunD/AP-1 and activated STATs drive high Bcl6 expression in GC B cells. Since stimulation of splenic B cells with IL-4 or IL-21 induced high Bcl6 expression with induction of junD and activation of STATs, these cytokines may be inducers for its high expression in GC B cells. However, IL-21 but not IL-4 stimulation activated STAT3 in splenic B cells. Thus, IL-21 may be a major inducer for high Bcl6 expression in GC B cells.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16702165     DOI: 10.1093/intimm/dxl041

Source DB:  PubMed          Journal:  Int Immunol        ISSN: 0953-8178            Impact factor:   4.823


  35 in total

1.  SOCS3 deletion in B cells alters cytokine responses and germinal center output.

Authors:  Sarah A Jones; Christine A White; Lorraine Robb; Warren S Alexander; David M Tarlinton
Journal:  J Immunol       Date:  2011-11-09       Impact factor: 5.422

Review 2.  Common mechanisms for the regulation of B cell differentiation and transformation by the transcriptional repressor protein BCL-6.

Authors:  Saritha Kusam; Alexander Dent
Journal:  Immunol Res       Date:  2007       Impact factor: 2.829

Review 3.  NF-kappaB pathways in the immune system: control of the germinal center reaction.

Authors:  Christine A Goetz; Albert S Baldwin
Journal:  Immunol Res       Date:  2008       Impact factor: 2.829

Review 4.  Expression patterns of the activator protein-1 (AP-1) family members in lymphoid neoplasms.

Authors:  Alexandra Papoudou-Bai; Eleftheria Hatzimichael; Alexandra Barbouti; Panagiotis Kanavaros
Journal:  Clin Exp Med       Date:  2016-09-06       Impact factor: 3.984

5.  Bcl6 middle domain repressor function is required for T follicular helper cell differentiation and utilizes the corepressor MTA3.

Authors:  J Philip Nance; Simon Bélanger; Robert J Johnston; Joyce K Hu; Toshitada Takemori; Shane Crotty
Journal:  Proc Natl Acad Sci U S A       Date:  2015-10-12       Impact factor: 11.205

6.  Novel IL-21 signaling pathway up-regulates c-Myc and induces apoptosis of diffuse large B-cell lymphomas.

Authors:  Kristopher A Sarosiek; Raquel Malumbres; Hovav Nechushtan; Andrew J Gentles; Eli Avisar; Izidore S Lossos
Journal:  Blood       Date:  2009-11-20       Impact factor: 22.113

Review 7.  New insights into the regulation of human B-cell differentiation.

Authors:  Heike Schmidlin; Sean A Diehl; Bianca Blom
Journal:  Trends Immunol       Date:  2009-05-15       Impact factor: 16.687

8.  IL-21 regulates germinal center B cell differentiation and proliferation through a B cell-intrinsic mechanism.

Authors:  Dimitra Zotos; Jonathan M Coquet; Yang Zhang; Amanda Light; Kathy D'Costa; Axel Kallies; Lynn M Corcoran; Dale I Godfrey; Kai-Michael Toellner; Mark J Smyth; Stephen L Nutt; David M Tarlinton
Journal:  J Exp Med       Date:  2010-02-08       Impact factor: 14.307

9.  STAT3-mediated up-regulation of BLIMP1 Is coordinated with BCL6 down-regulation to control human plasma cell differentiation.

Authors:  Sean A Diehl; Heike Schmidlin; Maho Nagasawa; Simon D van Haren; Mark J Kwakkenbos; Etsuko Yasuda; Tim Beaumont; Ferenc A Scheeren; Hergen Spits
Journal:  J Immunol       Date:  2008-04-01       Impact factor: 5.422

Review 10.  IL-21 acts as a promising therapeutic target in systemic lupus erythematosus by regulating plasma cell differentiation.

Authors:  Xiao-Mei Deng; Shang-Xue Yan; Wei Wei
Journal:  Cell Mol Immunol       Date:  2014-08-04       Impact factor: 11.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.